Highlights
NASDAQ: GLPG       Galapagos NV
Last Price Today's Change   Day's Range   Trading Volume
183.75   -0.05 (0.03%)  182.07 - 184.95  285,000

Overview

 
Avg Volume (4 weeks):157,725
4 Weeks Range:154.85 - 192.89
4 Weeks Price Volatility (%):
75.97%
52 Weeks Range:85.00 - 192.89
52 Weeks Price Volatility (%):
91.53%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Galapagos is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company’s product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

  Be the first to like this.
 


 

4308  3684  701  236 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.70+0.01 
 EEM 43.13+0.34 
 AMD 38.56+0.21 
 SPY 311.79+2.24 
 ACB 2.73-0.56 
 AIHS 1.07+0.65 
 AMRN 24.02+2.53 
 FCEL 0.825-0.064 
 TVIX 7.12-0.71 
 UBER 26.79+0.80 
Partners & Brokers